Home > Insider Trading > Filing (0001209191-19-035533)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1300699	Athenex Inc.	ATNX	Pharmaceutical Preparations (2834)	431985966

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1772350	Jordan Kanfer	C/O Athenex, Inc. 1001 Main Street, Suite 600 Buffalo NY 14203		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-06-06	2,500	$15.01	4,184	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$12.06		2029-04-01	10,000	10,000	Direct
Common Stock	Stock Option (Right to Buy)	$11.49		2029-04-03	2,500	2,500	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2029-04-01	10,000	10,000	Direct
2029-04-03	2,500	2,500	Direct

Footnotes

This transaction was executed in multiple trades ranging from $15.00 to $15.02. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected.
This option vests in four equal annual installments beginning on April 1, 2020.
This option vests in four equal annual installments beginning on April 3, 2020.